| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 10/26/2006 | WO2006094237A3 Acridine and quinoline dervatives as sirtuin modulators |
| 10/26/2006 | WO2006093666A3 Isoqunoline compounds and methods of use thereof |
| 10/26/2006 | WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 10/26/2006 | WO2006078621B1 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 10/26/2006 | WO2006074057A3 Pyrimidine derivatives as kinase modulators and method of use |
| 10/26/2006 | WO2005105778A3 4-amino-5-cyanopyrimidine derivatives |
| 10/26/2006 | WO2005099353A3 A novel process for the preparation of linezolid and related compounds |
| 10/26/2006 | WO2005095384A8 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists |
| 10/26/2006 | WO2005090311A8 Novel heterocyclyl-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors |
| 10/26/2006 | US20060241304 Reaction of a 2-carboxypyrrole or 3-carboxy-2H-pyrazole with a sulfonyl chloride and further condensation with an isatoic anhydride in the presence of a tertiary amine to form the 2-(pyrrol-2-yl or pyrazol-3-yl)benzo[1,3]oxazin-4-one; intermediates for crop protection agents and pharmaceuticals |
| 10/26/2006 | US20060241160 Zolmitriptan crystal forms |
| 10/26/2006 | US20060241159 Zolmitriptan crystal forms |
| 10/26/2006 | US20060241158 Zolmitriptan crystal forms |
| 10/26/2006 | US20060241149 Chemical compounds |
| 10/26/2006 | US20060241146 2-cyano-1-[t-4-(4-acetyl-1-piperazinyl)-1-methyl-r-1-cyclohexylamino]acetylpyrrolidine; dipeptidylpeptidase IV (DPPIV) inhibitor; antidiabetic, insulin resistance, hyperglycemia, obesity; antiproliferative agent for T-cell, HIV, AIDS; arthritis, osteoporosis |
| 10/26/2006 | US20060241117 Therapeutic agents useful for treating pain |
| 10/26/2006 | US20060241115 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer |
| 10/26/2006 | US20060241112 Kinase inhibitors |
| 10/26/2006 | US20060241111 inhibitors of coagulation factor Xa such as 1-(5-chlorothien-2-ylcarbonyl)-4-[4-(3-oxomorpholin-4-yl)phenyl]-2-propylsemicarbazide, used for preventing thrombosis, infarction, arteriosclerosis, inflammation, bleeding, angina pectoris, restenosis, intermittent claudication and treatment of tumors |
| 10/26/2006 | US20060241110 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 10/26/2006 | US20060241109 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 10/26/2006 | US20060241106 Isoxazole compounds as inhibitors of heat shock proteins |
| 10/26/2006 | US20060241105 To control arthropods (including insects and arachnids) and helminths (including nematodes) also valuable to protect timber from sawflies, beetles or termites or use in veterinary medicine; 1-(2,6-Dichloro-4-trifluoromethylphenyl)-3-(N-benzyloxy-2-amidino)-5-methylamino-4-trifluoromethylsulfonylpyrazole |
| 10/26/2006 | US20060241096 Agent for preventing or treating organ functional disorders and organ dysfunction |
| 10/26/2006 | US20060240475 Detection of toxic gluten oligopeptides refractory to digestion by using antibodies and T cells responsive thereto; producing the antibodies by immunization of an animal |
| 10/26/2006 | US20060240455 Oxazine derivatives |
| 10/26/2006 | DE102005018690A1 Imino-oxazolidine und ihre Verwendung Imino-oxazolidines and their use |
| 10/26/2006 | DE102005018389A1 Azolderivate als Inhibitoren von Lipasen und Phospholipasen Azole derivatives as inhibitors of lipases and phospholipases |
| 10/26/2006 | CA2606301A1 Azole derivatives in the form of lipase and phospholipase inhibitors |
| 10/26/2006 | CA2606288A1 Subtituted heteroaryl cb1 antagonists |
| 10/26/2006 | CA2605778A1 Fused heterocyclic compound |
| 10/26/2006 | CA2605492A1 Iminooxazolidines and their use |
| 10/26/2006 | CA2604956A1 Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient |
| 10/26/2006 | CA2604942A1 2-amino-quinaz0lin-5-ones |
| 10/26/2006 | CA2604920A1 Novel compounds useful for bradykinin b1 receptor antagonism |
| 10/26/2006 | CA2601979A1 2,3 substituted pyrazine sulfonamides |
| 10/25/2006 | EP1714652A2 Use of thiazolidinediones to prevent or delay onset of niddm |
| 10/25/2006 | EP1713823A2 Hcv ns-3 serine protease inhibitors |
| 10/25/2006 | EP1713822A2 Hcv ns-3 serine protease inhibitors |
| 10/25/2006 | EP1713785A1 Halogenated biaryl heterocyclic compounds and methods of making and using the same |
| 10/25/2006 | EP1713782A1 Pth agonists |
| 10/25/2006 | EP1713778A1 Benzazepine derivatives as histamine h3 antagonists |
| 10/25/2006 | EP1713774A1 New pyridin-2-one compounds useful as inhibitors of thrombin |
| 10/25/2006 | EP1713484A2 Compounds and methods of use |
| 10/25/2006 | EP1554272B1 Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| 10/25/2006 | EP1397353B1 2-(2,6-disubstituted phenyl)-4-aryl-5-alkyl-1,3-oxazoline compounds useful as insecticides and acaricides |
| 10/25/2006 | EP1089998B1 Epothilone derivatives and their synthesis and use |
| 10/25/2006 | CN1852901A Organic compounds |
| 10/25/2006 | CN1852896A Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| 10/25/2006 | CN1852714A Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 10/25/2006 | CN1852712A Dual NK1/NK3 antagonists for treating schizophrenia |
| 10/25/2006 | CN1852710A Pyrazolines as PAR-1 antagonists for treatment of cardiovascular diseases |
| 10/25/2006 | CN1850821A Benzoxazine containing maleimide and allyl ether and its preparing method |
| 10/25/2006 | CN1281585C Cyclic diamine compounds having fused-ring groups |
| 10/24/2006 | US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 10/24/2006 | US7126005 Process for preparing florfenicol |
| 10/24/2006 | US7125995 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS) |
| 10/24/2006 | US7125994 PNA monomer and precursor |
| 10/24/2006 | US7125990 For treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms |
| 10/24/2006 | US7125989 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene |
| 10/24/2006 | US7125896 Thiophene carboxamide compounds as inhibitors of enzyme IKK-2 |
| 10/24/2006 | US7125893 Compounds useful for treatment of tumors or cancer of the stomach, colon, neck or used in angiogenesis and forming the compound with cyclization |
| 10/24/2006 | US7125892 Aryl aniline β2 adrenergic receptor agonists |
| 10/24/2006 | US7125891 Such as (1-((2,3-dihydro-2-(4-propyl-1H-imidazol-2-yl)-1H-indol-1 -yl)carbonyl)propyl)-carbamate; for inactivation of cholecystokinins |
| 10/24/2006 | US7125881 Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives |
| 10/24/2006 | US7125879 Prevention reproduction of virus |
| 10/24/2006 | US7125876 Substituted heterocyclic compounds |
| 10/24/2006 | US7125870 such as N-hydroxy-2-{3-[4-(2-methyl-quinolin-4-ylmethoxy)-phenyl]-4,5-dihydro-isoxazol-5-yl}-acetamide; kits; for treatment of inflammation |
| 10/24/2006 | US7125866 Therapeutic applications of pro-apoptotic benzodiazepines |
| 10/24/2006 | US7125865 and atherosclerosis; LXR agonists which increase HDL levels; increases ABCA1 gene expression; reverse cholesterol transport; 1,2-benzisoxazole 6-yl compounds |
| 10/24/2006 | US7125863 Inhibitors of dipeptidyl peptidase IV |
| 10/24/2006 | CA2252952C Substituted aminomethylphenylsulphonylureas, their preparation, and their use as herbicides and plant growth regulators |
| 10/24/2006 | CA2246678C Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)ones as herbicides |
| 10/24/2006 | CA2223094C Phenylpyridazinones |
| 10/24/2006 | CA2222517C Agents for use against parasitic protozoa |
| 10/24/2006 | CA2158400C Synthesis of 3-[4-(2-aminoethoxy)-benzoyl]-2-aryl-6-hydroxybenzo[b]thiophenes |
| 10/19/2006 | WO2006109846A1 Triazole derivative and the use thereof |
| 10/19/2006 | WO2006109817A1 1,4-substituted piperazine derivative |
| 10/19/2006 | WO2006109026A1 4-(pyrid-2-yl) amino substituted pyrimidine as protein kinase inhibitors |
| 10/19/2006 | WO2006108837A1 Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers |
| 10/19/2006 | WO2006108701A1 3- (1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors |
| 10/19/2006 | WO2006108700A1 3-triazolylthioalkyl-3-azabicyclo (3 - 1 - o) hexanes and their use as dopamine d3 receptor ligands |
| 10/19/2006 | WO2006108671A1 3,4-dihydro-benzo[e][1,3]oxazin-2-ones |
| 10/19/2006 | WO2006108591A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 10/19/2006 | WO2006050476A3 Pyrimidine derivatives as ion channel modulators and methods of use |
| 10/19/2006 | WO2005103041A3 Treatment of cns disorders using cns target modulators |
| 10/19/2006 | US20060235222 Indole-derivative modulators of steroid hormone nuclear receptors |
| 10/19/2006 | US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent |
| 10/19/2006 | US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same |
| 10/19/2006 | US20060235022 Therapeutic agents useful for treating pain |
| 10/19/2006 | US20060235017 e.g. 1-Methyl-7-(pyrimidin-4-yloxy)-1H-indole-2-carboxylic acid (5-tert-butyl-3-methanesulfonylamino-2-methoxy-phenyl)-amide; antiinflammatory, antidiabetic, analgesic agent; osteoarthritis, atherosclerosis, contact dermatitis, bone resorption diseases, reperfusion injury, asthma |
| 10/19/2006 | US20060235016 Morpholine Dopamine Agonists |
| 10/19/2006 | US20060235015 Pyrrole-2,5-dione derivatives as liver x receptor modulators |
| 10/19/2006 | US20060235010 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives |
| 10/19/2006 | US20060235007 Substituted 1,4-diazepines and uses thereof |
| 10/19/2006 | US20060235004 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
| 10/19/2006 | US20060235000 Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders |
| 10/19/2006 | US20060234984 Mitotic kinesin inhibitors |
| 10/19/2006 | CA2604773A1 Npy antagonists, preparation and use |
| 10/19/2006 | CA2604356A1 Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2h-chromen-6-yl derivatives and their use as potassium channel blockers |